Publicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (18)

2022

  1. Vitamin D Receptor and Binding Protein Gene Variants in Patients with Essential Tremor

    Molecular Neurobiology, Vol. 59, Núm. 6, pp. 3458-3466

2020

  1. Memory and Executive Dysfunction Predict Complex Activities of Daily Living Impairment in Amnestic Multi-Domain Mild Cognitive Impairment

    Journal of Alzheimer's disease : JAD, Vol. 75, Núm. 3, pp. 1061-1069

2019

  1. Neurological disorders in central Spain, second survey: Feasibility pilot observational study

    Journal of Medical Internet Research, Vol. 21, Núm. 1

2017

  1. Delta-amino-levulinic acid dehydratase gene and essential tremor

    European Journal of Clinical Investigation, Vol. 47, Núm. 5, pp. 348-356

2013

  1. No association of the SLC1A2 rs3794087 allele with risk for essential tremor in the Spanish population

    Pharmacogenetics and Genomics, Vol. 23, Núm. 11, pp. 587-590

2012

  1. H1-MAPT and the risk for familial essential tremor

    PLoS ONE, Vol. 7, Núm. 7

  2. Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: The ANIMO study

    Movement Disorders, Vol. 27, Núm. 2, pp. 211-218

2011

  1. Gamma-aminobutyric acid (GABA) receptor rho (GABRR) polymorphisms and risk for essential tremor

    Journal of Neurology, Vol. 258, Núm. 2, pp. 203-211

  2. Gamma-aminobutyric acid GABRA4, GABRE, and GABRQ receptor polymorphisms and risk for essential tremor

    Pharmacogenetics and Genomics, Vol. 21, Núm. 7, pp. 436-439

  3. Methods and design of the baseline survey of the neurological disorders in Salamanca (NEDISA) cohort: A population-based study in Central-Western Spain

    Neuroepidemiology, Vol. 36, Núm. 1, pp. 62-68

2010

  1. Does the combination of the MMSE and clock drawing test (mini-clock) improve the detection of mild Alzheimer's disease and mild cognitive impairment?

    Journal of Alzheimer's Disease, Vol. 22, Núm. 3, pp. 889-896

  2. Paraoxonase 1 (PON1) polymorphisms and risk for essential tremor

    European Journal of Neurology, Vol. 17, Núm. 6, pp. 879-881

2009

  1. Dopamine Receptor D3 (DRD3) genotype and allelic variants and risk for essential tremor

    Movement Disorders, Vol. 24, Núm. 13, pp. 1910-1915

2008

  1. Glutathione-S-transferase P1 polymorphism and risk for essential tremor

    European Journal of Neurology, Vol. 15, Núm. 3, pp. 234-238

  2. The nonsynonymous Thr105Ile polymorphism of the histamine N-methyltransferase is associated to the risk of developing essential tremor

    NeuroMolecular Medicine, Vol. 10, Núm. 4, pp. 356-361

2007

  1. Alcohol dehydrogenase 2 genotype and allelic variants are not associated with the risk for essential tremor

    Clinical Neuropharmacology, Vol. 30, Núm. 4, pp. 196-200

  2. Changes at the CYP2C locus and disruption of CYP2C8/9 linkage disequilibrium in patients with essential tremor

    NeuroMolecular Medicine, Vol. 9, Núm. 2, pp. 195-204

2006

  1. CYP2C19 polymorphism and risk for essential tremor

    European Neurology, Vol. 56, Núm. 2, pp. 119-123